Market: NASD |
Currency: USD
Address: 221 Crescent Street
Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Show more
📈 Viridian Therapeutics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$39.13
-
Upside/Downside from Analyst Target:
109.72%
-
Broker Call:
30
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
2025-11-10
-
EPS Estimate:
-0.94
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2020 |
- |
$0.066667 |
- |
2020-11-13 |
- |
Stock split |
|
Total Amount for 2020: $0.066667 |
| 2016 |
- |
$0.066667 |
- |
2016-11-07 |
- |
Stock split |
|
Total Amount for 2016: $0.066667 |
📅 Earnings & EPS History for Viridian Therapeutics, Inc.
| Date | Reported EPS |
|---|
| 2025-11-10 (estimated upcoming) | - |
| 2025-08-06 | -1 |
| 2025-05-06 | -0.87 |
| 2025-02-26 | -0.81 |
| 2024-11-12 | -1.15 |
| 2024-08-08 | -1.02 |
| 2024-05-08 | -0.79 |
| 2024-02-27 | -1.35 |
| 2023-11-13 | -1.09 |
| 2023-08-08 | -1.27 |
| 2023-05-10 | -1.61 |
| 2023-03-08 | -1.13 |
| 2022-11-14 | -0.86 |
| 2022-08-15 | -1.06 |
| 2022-05-12 | -0.98 |
| 2022-03-10 | -1.32 |
| 2021-11-05 | -1.25 |
| 2021-08-11 | -2.21 |
| 2021-05-07 | -2.91 |
| 2021-03-26 | -30.74 |
| 2020-11-10 | -1.5 |
| 2020-08-05 | -1.8 |
| 2020-05-07 | -2.7 |
| 2020-03-11 | -4.65 |
| 2019-11-07 | -5.4 |
📰 Related News & Research
No related articles found for "viridian therapeutics".
